Clinical trial · Interventional
Incidence of Residual Neuromuscular Blockade in Fraility in OncoGynae Surgery
Incidence of Residual Neuromuscular Blockade in Patients With Frailty Undergoing Gynecologic Cancer Surgery
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Frailty among patients undergoing surgery is strongly associated with an elevated risk of adverse perioperative outcomes, heightened incidence of postoperative complications, increased mortality rates, and prolonged hospital length of stay. Our focus centers on investigating the frailty index in the context of complications experienced by patients undergoing oncologic gynecology surgery. The principal objective of this research is to elucidate the extent to which residual neuromuscular blocking agents are linked to frailty.
Conditions
Conditions (5)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Frailty | — | UNRESOLVED | — |
| General Anesthetic Drug Adverse Reaction | — | UNRESOLVED | — |
| Gynecologic Cancer | Malignant Female Reproductive System Neoplasm | ALIAS | 0.90 |
| Neuromuscular Blockade | — | UNRESOLVED | — |
| Surgical Complication | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Train of four nerve stimulator | Diagnostic Test | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- TOF nerve stimulation
- description
- Patient receive TOF nerve stimulation in recovery room after surgery
- interventionNames
- Diagnostic Test: Train of four nerve stimulator
Primary outcomes (2)
- measure
- Incidence of residual neuromuscular blockade
- timeFrame
- 0-30 minute after surgery
- description
- Incidence of residual neuromuscular blockade with the relation of frailty after gynecologic oncology surgery
- measure
- Incidence of frailty
- timeFrame
- 0 - 24 hours preoperative
- description
- Incidence of frailty in patients undergoing gynecologic oncology surgery
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Age \>,= 18 years * Patients undergoing elective gynecologic-oncology surgery Exclusion Criteria: * Unable to communicate Thai * Unable to understand the questionnaire * Preexisting neuromuscular disease * Preexisting disease involved wrist that may affect the nerve stimulator examination
References
Publications (0)
Data not yet available